Sabra Healthcare REIT Inc’s recent filing unveils that its Director Cusack Catherine acquired Company’s shares for reported $23880.0 on Feb 24 ’25. In the deal valued at $15.92 per share,1,500 shares were bought. As a result of this transaction, Cusack Catherine now holds 60,583 shares worth roughly $1.01 million.
Then, Cusack Catherine bought 1,000 shares, generating $16,435 in total proceeds. Upon buying the shares at $16.43, the Director now owns 59,083 shares.
Before that, Cusack Catherine bought 7,000 shares. Sabra Healthcare REIT Inc shares valued at $101,010 were divested by the Director at a price of $14.43 per share. As a result of the transaction, Cusack Catherine now holds 46,385 shares, worth roughly $0.77 million.
Truist downgraded its Sabra Healthcare REIT Inc [SBRA] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including JMP Securities’s analysts, who increased its forecast for the stock in early January from “a Mkt perform” to “a Mkt outperform”. Mizuho also remained covering SBRA and has decreased its forecast on December 05, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. Wells Fargo revised its rating on October 01, 2024. It rated SBRA as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of SBRA
On Friday, Sabra Healthcare REIT Inc [NASDAQ:SBRA] saw its stock jump 0.97% to $16.61. Over the last five days, the stock has gained 4.53%. Sabra Healthcare REIT Inc shares have fallen nearly -4.10% since the year began. Nevertheless, the stocks have risen 19.16% over the past one year. While a 52-week high of $19.99 was reached on 01/28/25, a 52-week low of $13.22 was recorded on 02/21/25. SMA at 50 days reached $16.78, while 200 days put it at $16.88.
Levels Of Support And Resistance For SBRA Stock
The 24-hour chart illustrates a support level at 16.48, which if violated will result in even more drops to 16.35. On the upside, there is a resistance level at 16.72. A further resistance level may holdings at 16.83. The Relative Strength Index (RSI) on the 14-day chart is 50.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.46%. Stochastics %K at 68.10% indicates the stock is a holding.
